Taming the beloved beast: How medical technology costs are destroying our health care system

Taming the Beloved Beast: How Medical Technology Costs Are Destroying Our Health Care System

Volumn , Issue , 2009, Pages

  Callahan, Daniel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79957964744     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (361)

1. Joseph P. Newhouse, "Medical Care: How Much Welfare Loss?" Journal of Economic Perspectives 6, no. 3 (1992): 3-21;
2. Thomas Bodenheimer, "High and Rising Health Care Costs. Part 2: Technologic Innovation," Annals of Internal Medicine 142, no. 11 (2005): 932-937;
3. Congressional Budget Office, Technological Change and the Growth of Health Care Spending (Washington, D.C.: Congressional Budget Office, 2008);
4. Micah Hartman et al., "U.S. Health Spending by Age, Selected Years Through 2004," Health Affairs (Web Exclusive, 2007): W1-W12.
5. A 1998 study summarized the findings of 12 studies between 1971 and 1998 detailing the impact of technology on cost growth: M. E. Chernew et al., "Managed Care, Medical Technology and Health Care Cost Growth: A Review of the Evidence," Medical Care Research and Review 55, no. 3 (1998): 274-275;
6. E. A. Peden and M. S. Freeland, "A Historical Analysis of Medical Spending Growth, 1960-1993," Health Affairs 14 (1995): 235-247.
7. Sean Keehan et al., "Health Spending Projections Through 2017: The Baby Boom Generation Is Coming to Medicare," Health Affairs (Web Exclusive, 2008): W145-155.
8. Quoted in Gardiner Harris, "British Balance Benefit vs. Cost of Latest Drugs," The New York Times, December 3, 2008: A1.
9. Ezekiel J. Emanuel and Victor R. Fuchs, "The Perfect Storm of Overutilization," JAMA 29, no. 23 (2008): 2789-94.
10. Cathy Schoen et al., "How Many Are Underinsured? Trends among U.S. Adults, 2003 and 2007," Health Affairs (Web Exclusive, 2008): W298-W309.
11. Kaiser Family Foundation, "Comparing Projected Growth in Health Care Expenditures and the Economy," in Snapshots: Health Care Costs (Menlo Park, CA: Kaiser Family Foundation, 2006).
12. See particularly Paul B. Ginsburg, "Health and Rising Health Care Costs," (Princeton: The Robert Wood Johnson Foundation, Synthesis Report no. 16, November 6, 2008).
13. Congressional Budget Office, Technological Change and the Growth of Health Care Spending (Washington, D.C.: Congressional Budget Office, 2008).
14. E.A. Powell, "Fidelity: Couple Needs $225,000 to Cover Health Care in Retirement," AP Business Wire, March 5, 2008.
15. Marilyn Moon, "Confronting the Rising Costs of Healthcare and Medicaid," Generations (Spring 2005): 62-63.
16. Christine K. Cassell, Medicare Matters: What Geriatric Medicine Can Teach American Health Care (Berkeley: University of California Press, 2005): 18.
17. Muriel Gillick, The Denial of Aging: Perpetual Youth, Eternal Life, and Other Dangerous Fantasies (Cambridge: Harvard University Press, 2006): 94;
18. Robert A. Berenson and Jane Horvath, "Confronting the Barriers to Chronic Management in Medicare," Health Affairs (Web Exclusive, 2002): W3-37-53.
19. David A. Hyman, "Medicare Meets Mephistopheles," Washington and Lee Law Review 50, no. 4 (2003): 1184.
20. Jonathan Oberlander, The Political Life of Medicare (Chicago: University of Chicago Press, 2003): 4.
21. Bruce C. Vladeck, "The Struggle for the Soul of Medicare," Journal of Law, Medicine and Ethics 32, no. 3 (2004): 412.
22. Hyman, "Medicare Meets Mephistopheles," 1201.
23. Cassell, Medicare Matters, 18.
24. "Medicare 'Drifting Toward Disaster': U.S. Official," Reuters, April 29, 2008.
25. Peter S. Heller, Who Will Pay? Coping with Aging Societies, Climate Change, and Other Long-Term Fiscal Responsibilities (Washington, D.C.: International Monetary Fund, 2003): 222.
26. Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds Board of Trustees, 2008 Annual Report (Washington, D.C.: Government Printing Office, 2008): 3-4.
27. Congressional Budget Office, The Long-Term Budget Outlook (Washington, D.C.: Congressional Budget Office: 2003): 29-30.
28. Geoffrey Kollmann and Dawn Nuschler, "The Financial Outlook for Social Security and Medicare," CRS Report for Congress (Washington, D.C.: Congressional Research Service, 2004): CRS 1-6.
29. Oberlander, The Political Life of Medicare, 93-95.
30. Marilyn Moon, Medicare: A Policy Primer (Washington, D.C.: The Urban Institute Press, 2006): 163.
31. Oberlander, The Political Life of Medicare, 99.
32. Congressional Budget Office, The Long-Term Budget Outlook, 32.
33. Jill Bernstein and Rosemary A. Stevens, "Public Opinion, Knowledge, and Medicare Reform," Health Affairs 8, no. 1 (1999): 188-189.
34. Greg M. Shaw and Sarah E. Mysiewicz, "Social Security and Medicare," Public Opinion Quarterly 68, no. 3 (2004): 416.
35. Becky Bright, "Reducing Uninsured Seen as Top Health Care Issue, Poll Finds," Wall Street Journal, October 24, 2006.
36. Bernstein and Stevens, "Public Opinion, Knowledge, and Medicare Reform," 190-191.
37. Kaiser Family Foundation Public Opinion and Survey Research Program, "Kaiser Health Tracking Poll: Election 2008-April 2008," http://www.kff.org/kaiserpolls/h08-_pomr042908pkg.cfm/.
38. Lewis Thomas, The Lives of a Cell (New York: Bantam Books, 1974).
39. Blue Cross Blue Shield Association, Medical Cost Reference Guide 2008 (Chicago: Blue Cross Blue Shield Association, 2008): 49.
40. James F. Fries, "The Compression of Morbidity," Milbank Quarterly 61, no. 3 (1983): 347-419.
41. Congressional Budget Office, Technological Change, 13.
42. Alan M. Garber and Dana P. Goldman, "The Changing Face of Health Care," in Coping With Methuselah: The Impact of Molecular Biology on Medicine and Society, ed. Henry J. Aaron and William B. Schwartz (Washington, D.C.: Brookings Institution Press, 2004): 111;
43. Dana P. Goldman et al., "Consequences of Health Trends and Medical Innovation for the Future Elderly," Health Affairs 24, suppl. 2 (2005): R5-17.
44. David M. Cutler, Allison B. Rosen, and Sandeep Vijan, "The Value of Medical Spending in the United States, 1960-2000," New England Journal of Medicine 355, no. 9 (2006): 923.
45. Jonathan Skinner and Elliott S. Fisher, The Efficiency of Medicare (Cambridge, MA: National Bureau of Economics, 2001): 22.
46. Goldman, "Consequences of Health Trends and Medical Innovation for the Future Elderly," R5-R16.
47. Geoffrey F. Joyce et al., "The Lifetime Burden of Chronic Disease among the Elderly," Health Affairs 24, supplement 2 (2005): R18-R29;
48. Michael Chernew et al., "Barriers to Constructing Health Care Cost Growth," Health Affairs 23, no. 6 (2004): 122-128;
49. Jayanta Bhattacharya et al., "Technological Advances in Cancer and Future Spending by the Elderly," Health Affairs 24, supplement 2 (2005): R53-R56;
50. James Lubitz, "Health, Technology, and Medical Spending," Health Affairs 24, web exclusive 2 (2005): 83.
51. Darios K. Lakdawalla, Dana P. Goldman, and Baoping Shang, "The Health and Cost Consequences of Obesity among the Future Elderly," Health Affairs 24, supplement 2 (2005): R30.
52. Bhattacharya et al., "Technological Advances," R53-R56.
53. David M. Cutler, "The Potential for Cost Savings in Medicare's Future," Health Affairs 24, supplement 2 (2005): WR-R78.
54. Cassell, Medicare Matters, 198, 41.
55. Joseph White, False Alarm: Why the Greatest Threat to Social Security and Medicare Is the Campaign to "Save" Them (Baltimore: The Johns Hopkins University Press, 2001): 2.
56. Laura McGinley, "A Guide to Who Wins and Who Loses in Medicare Bill," Wall Street Journal, November 18, 2003.
57. Dick Armey, "Say 'No' to the Medicare Bill,"Wall Street Journal, November 21, 2003.
58. Regina Herzlinger, Who Killed Health Care? America's $2 Trillion Medical Problem-and the Consumer-Driven Cure (New York: McGraw-Hill, 2007).
59. Kenneth G. Manton, Xi Liang Gu, and Vicki L. Lamb, "Long-Term Trends in Life Expectancy and Active Life Expectancy in the United States," Population and Development Review 32, no. 1 (2006): 81-105;
60. Alicia H. Munnell, Robert E. Hatch, and James G. Lee, Why Is Life Expectancy So Low in the United States? (Boston: Center for Retirement Research, 2001), http://crr.bc.edu/briefs/why_is_life_expectancy_so_low_in_the_united_states_.html/.
61. The Heritage Foundation, "Lessons of Success: What Congress Can Learn from the Federal Employees Program," Robert E. Moffit, http://www.heritage.org/Research/HealthCare/wm565.cfm;
62. Walton Francis, Using the Federal Employees' Model: Nine Tests for Rational Medicare Reform: Heritage Foundation Backgrounder #1675 (Washington, D.C.: The Heritage Foundation, 2003);
63. David Gratzer, The Cure: How Capitalism Can Save American Health Care (New York: Encounter Books, 2006): 133-137.
64. Greg Scandlen, "Defined Contribution Health Insurance," Policy Backgrounder, no. 15 (Washington, D.C.: Center for Policy Analysis, 2000).
65. Ezekial J. Emanuel and Victor R. Fuchs, "Health Care Vouchers-A Proposal for Universal Coverage," New England Journal of Medicine 352, no. 12 (2005): 1255.
66. Brian Biles, Emily Adrion, Stuart Guterman, "The Continuing Costs of Privatization: Extra Payments to Medicare Advantage," e-alert, The Commonwealth Fund, September 5, 2008.
67. Marilyn Moon, Medicare: A Policy Primer, 100.
68. Mark Schlesinger, "Markets as Belief Systems and Those Who Keep the Faith," Journal of Health Politics, Policy, and Law 31, no. 3 (2006): 417-421;
69. Theodore R. Marmor, The Politics of Medicare, 2nd edition (New York: Aldine Transaction, 2000).
70. Sarah Thomson and Elias Mossialos, What are the Equity, Efficiency and Choice Implications of Private Health-Care Funding in Western Europe? (Copenhagen: World Health Organization Regional Office for Europe, 2004):10.
71. Kaiser Family Foundation, "Comparing Projected Growth in Health Care Expenditures and the Economy," in Snapshots: Health Care Costs (Menlo Park, CA: Kaiser Family Foundation, 2006): 3.
72. Sherry Glied, "Health Care Costs on the Rise Again," Journal of Economic Perspectives 17, no. 2 (2003): 145.
73. Moon, Medicare Matters, 164.
74. Vladeck, "The Struggle for the Soul of Medicare," 415.
75. Daniel Callahan, "How Much Is Enough or Too Little: Assessing Health Care Demand in Developed Countries," in Comprehensive Medicinal Chemistry II, vol. 1, ed. John B. Taylor and David J. Triggle (Amsterdam: Elsevier, 2007): 627-636.
76. Kaiser Family Foundation, "Health Care Spending in the United States and OECD Countries," in Snapshots: Health Care Costs (Menlo Park, CA: Kaiser Family Foundation, 2007), http://www.kff.org/insurance/snapshot/chcm010307oth.cfm/.
77. Kenneth E. Thorpe, Impact on Health Care Reform: Projections of Cost and Savings (Washington, D.C.: National Coalition on Health Care, 2005).
78. Alan B. Cohen and Ruth S. Hanft, ed., Technology in American Health Care (Ann Arbor: University of Michigan, 2004): 19;
79. Joseph P. Newhouse, "Medicare Spending on Physicians-No Easy Fix in Sight," New England Journal of Medicine 356, no. 18 (2007): 1883-1884.
80. Patrice Bourdelais, Epidemics Laid Low: A History of What Happened in Rich Countries, trans. Bart K. Holland (Baltimore: Johns Hopkins University Press, 2006): 138.
81. Richard White, "The Nature of Progress: Progress and the Environment," in Progress: Fact or Illusion?, ed. Leo Marx and Bruce Mazlish (Ann Arbor, University of Michigan Press, 1996): 134.
82. Richard D. Lamm and Robert H. Blank, Condition Critical: A New Moral Vision for Health Care (Golden, CO: Fulcrum Publishing, 2007).
83. Alastair J. J.Wood, "When Increased Therapeutic Benefit Comes at Increased Cost," New England Journal of Medicine 346, no. 23 (2002): 1820.
84. Marjorie E. Ginsburg, "A Survey of Physician Attitudes and Practices Concerning Cost-Effectiveness in Patient Care," Western Journal of Medicine 173, no. 6 (2000): 392.
85. Henry J. Aaron and William B. Schwartz, Can We Say No? The Challenge of Rationing Health Care (Washington, D.C.: The Brookings Institution Press, 2005): 6.
86. Alan M. Garber and Dana P. Goldman, "The Changing Face of Health Care," in Coping With Methuselah: The Impact of Molecular Biology on Medicine and Society, ed. Henry J. Aaron and William B. Schwartz (Washington, D.C.: Brookings Institution Press, 2004): 123.
87. Robert J. Samuelson, "The Medicare Monster," The Washington Post, September 14, 2006;
88. Henry J. Aaron, "The Unsurprising Surprise of Renewed Health Care Cost Inflation," Health Affairs (Web Exclusive, 2002): W85-W87.
89. Tyler Cowen, "Poor U.S. Scores in Health Care Don't Measure Nobels and Innovation," New York Times, December 3, 2007.
90. Molly J. Coye and Jason Kell, "How Hospitals Confront New Technology," Health Affairs 25, no. 1 (2006): 163;
91. Barry M. Straube, "How Changes in the Medicare Coverage Process Have Facilitated the Spread of New Technologies," Health Affairs (Web Exclusive, 2005): W314-W316.
92. Susan B. Foote, Managing the Medicare Arms Race: Public Policy and Medical Device Innovation (Berkeley: University of California Press, 1992).
93. Jacqueline Fox, "Medicare Should, but Cannot, Consider Cost: Legal Impediments to a Sound Policy," Buffalo Law Review 53, no. 2 (2005): 577-633;
94. Susan B. Foote and Lynn A. Blewett, "Politics of Prevention: Expanding Prevention Benefits in the Medicare Program," Journal of Public Health Policy 24, no. 1 (2003): 26-40;
95. Sean R. Tunis, "Why Medicare Has Not Established Criteria for Coverage Decisions," New England Journal of Medicine 350, no. 21 (2004): 2196-2198;
96. Peter J. Neumann, Using Cost-Effective Analysis to Improve Health Care (New York: Oxford University Press, 2005).
97. Muriel R. Gillick, "Molecular Medicine, The Medicare Drug Benefit, and the Need for Cost Control," Journal of the American Geriatrics Society 54, no. 9 (2006): 1442-1446.
98. Henry J. Aaron, "Should Public Policy Seek to Control the Growth of Health Care Spending?" Health Affairs (Web Exclusive, 2003): W3-W31.
99. Minah Kim, Robert J. Blendon, and John M. Benson, "How Interested Are Americans in New Medical Technologies?" Health Affairs 20, no. 5 (2001): 194-201.
100. Janet K. Shim, Ann J. Russ, and Sharon R. Kaufman, "Risk, Life Extension and the Pursuit of Medical Possibility," Sociology of Health and Illness 38, no. 4 (2006): 479-502.
101. Carol J. De Frances and Margaret J. Hall, "2005 National Hospital Discharge Survey," Advance Data from Vital and Health Statistics 385 (Centers for Disease Control and Prevention, 2007): 1;
102. Sharon R. Kaufman, And a Time to Die: How American Hospitals Shape the End of Life (Chicago: University of Chicago Press, 2005).
103. Michael Chernew et al. "Barriers to Constraining Health Care Cost Growth," Health Affairs 23, no. 6 (2004): 123.
104. Susan B. Foote and Robert J. Town, "Implementing Evidence-Based Medicine through Medicine Coverage Decisions," Health Affairs 26, no. 6 (2007): 1634-1642.
105. Daniel Callahan, What Price Better Health? Hazards of the Research Imperative (Berkeley: University of California Press, 2006): 223-233.
106. Congressional Budget Office, Technological Change and the Growth of Health Care Spending (Washington, D.C.: Congressional Budget Office, 2008): 13.
107. H. Gilbert Welch et al., "What's Making Us Sick Is an Epidemic of Diagnoses," New York Times, January 2, 2007.
108. Laura A. Dummit, "Medicare Physician Payments and Spending," in National Health Policy Forum, Issue brief 185 (Washington, D.C.: The George Washington University Press, 2006): 4;
109. Barbara M. Rothenberg, Medical Technology as a Driver of Health Care Costs: Diagnostic Imaging (Washington, D.C.: Blue Cross Blue Shield Association, 2003), http://www.bcbs.com/betterknowledge/cost/diagnostic-imaging.html;
110. H. Gilbert Welch, Should I Be Tested for Cancer? (Berkeley: University of California Press, 2004).
111. Dummit, "Medicare Physician Payments and Spending," 4.
112. Julie Appleby, "The Case of CT Angiography: How Americans View and Embrace New Technology," Health Affairs 27, no. 6 (2008): 1515-21.
113. Coye and Kell, "How Hospitals Confront New Technology," 165.
114. Jeff Goldsmith, "Technology and the Boundaries of the Hospital: Three Emerging Technologies," Health Affairs 23, no. 6 (2004): 150.
115. Laurence Baker et al., "The Relationship between Technology Availability and Health Care Spending," Health Affairs (Web Exclusive, 2003): W537-W551.
116. Patricia M. Danzon and Mark V. Pauly, "Insurance and New Technology: From Hospital to Drugstore," Health Affairs 20, no. 5 (2005): 86-100.
117. Cindy L. Bryce and Ellen Cline, "The Supply and Use of Selected Medical Technologies," Health Affairs 17, no. 1 (1998): 221.
118. Muriel R. Gillick, "The Technological Imperative and the Battle for the Hearts of America," Perspectives in Biology and Medicine 50, no. 2 (2007): 276-294.
119. Aaron and Schwartz, Can We Say No?, 90.
120. Alan B. Cohen and Ruth S. Hanft, "Evaluation Concerns: Medical Technology Evaluation in the Future," in Technology in American Health Care ed. Alan B. Cohen and Ruth S. Hanft (Ann Arbor: University of Michigan, 2004): 364.
121. Joseph P. Newhouse, Free for All? Lessons from The Rand Health Insurance Experiment (Cambridge: Harvard University Press, 1993).
122. Joshua T. Cohen, Peter J. Neumann, and Milton C.Weinstein, "Does Prevention Save Money? Health Economics and the Presidential Candidates," New England Journal of Medicine 358, no. 7 (2008): 661-663.
123. Klim McPherson, "Does Preventing Obesity Lead to Reduced Health-Care Costs?" PLoS Medicine 5, no. 2 (2008): e37.
124. David M. Eddy, "Evidence-Based Medicine: A Unified Approach," Health Affairs 24, no. 1 (2005): 9.
125. Jill Eden et al., Knowing What Works in Health Care: A Roadmap for the Nation (Washington, D.C.: National Academies Press, 2008).
126. Uwe Reinhardt, "An Information Infrastructure for the Pharmaceutical Market," Health Affairs 23, no. 1 (2004): 107-112.
127. Stefan Timmermans and Aaron Mauck, "The Promise and Pitfalls of Evidence-Based Medicine," Health Affairs 24, no. 1 (2005): 18-28;
128. Dan Mendelson and Tanisha V. Carino, "Evidence-Based Medicine in the United States-De Rigueur or Dream Deferred?" Health Affairs 24, no. 1 (2005): 133-136;
129. Eddy, "Evidence-Based Medicine," 9-17;
130. Andrew Miles, Andreas Polychronis, and Joseph E. Grey, "The Evidence-Based Health Care Debate," Journal of Evaluation in Clinical Practice 12, no. 3 (2006): 239-247.
131. Gerard F. Anderson et al., "Health Care Spending and Use of Information Technology in OECD Countries," Health Affairs 25, no. 3 (2006): 819-831.
132. Rand Corporation, "Health Information Technology: Can HIT Lower Costs and Improve Technology?" in Rand Health: Research Highlights (Santa Monica: Rand Corporation, 2005).
133. Rainu Kaushal et al., "The Costs of a National Health Information Network," Annals of Internal Medicine 143, no. 3 (2005): 165-173.
134. Anderson et al., "Health Care Spending," 828.
135. Steven Lohr, "Smart Care Via a Mouse, but What Will It Cost?" New York Times, August 20, 2006.
136. National Conference of State Legislatures, "Certificate of Need: State Health Laws and Programs," (November 17, 2008); http://www.ncsl.org/programs/health/cert-need.htm.
137. Andrew Chernew, Richard A. Hirth, and Seema S. Sonnad, "Managed Care, Medical Technology, and Health Care Cost Growth," Medical Care Research and Review 55, no. 3 (1998): 259-288.
138. Karen Davis et al., Slowing the Growth of U.S. Health Care Expenditures: What Are the Options? (New York: The Commonwealth Fund, 2007).
139. Cathy Schoen et al., "Bending the Curve: Options for a Achieving Savings and Improving Value in U.S. Health Spending," The Commonwealth Fund 80 (2007).
140. Joseph R. Antos and Alice M. Rivlin, ed., "Strategies for Slowing the Growth of Health Spending," in Restoring Fiscal Sanity 2007: The Health Spending Challenge (Washington, D.C.: The Brookings Institution Press, 2007): 28-80.
141. Kenneth E. Thorpe and David H. Howard, "The Rise in Spending among Medicare Beneficiaries: The Role of Chronic Disease Prevalence and Changes in Treatment Intensity," Health Affairs (Web Exclusive, 2006): W378-W388.
142. Dana P. Goldman and Neeraj Sood, "Rising Medicare Costs: Are We in Crisis?" Health Affairs (Web Exclusive, 2006): W390.
143. Obama '08, "Barack Obama's Plan for a Healthy America: Lowering Health Care Costs and Ensuring Affordable, High-Quality Health Care for All," http://www.barackobama.com/pdf/issues/HealthCareFullPlan.pdf.
144. Max Baucus, "Health Care Reform 2009," (Washington, D.C.: Senate Finance Committee, November 12, 2008).
145. Thomas Daschle, Critical: What Can We Do About the Health Care Crisis (New York: St. Martin's Press, 2008).
146. The Healthy Americans Act, HR 3163, 110th Congress.
147. National Coalition on Health Care, Building a Better Health Care System: Specifications for Reform (Washington, D.C.: National Coalition on Health Care, 2004).
148. Donald J. Palmisano, David W. Emmons, and Gregory D. Wozniak, "Expanding Insurance Coverage through Tax Credits, Consumer Choice, and Market Enhancements: The American Medical Association Proposal for Health Insurance Reform," JAMA 291, no. 18 (2004): 2237-42.
149. Victor R. Fuchs and Ezekiel J. Emanuel, "Health Care Reform: Why? What? When?" Health Affairs 24, no. 6 (2005): 1399-1414;
150. Ezekiel J. Emanuel, Health Care Guaranteed (New York: Public Affairs, 2008).
151. Kaiser Family Foundation, "Kaiser Health Tracking Poll: Election 2008," http://www.kff.org/kaiserpolls/upload/7807.pdf/.
152. Editorial, "The Battle Over Health Care," New York Times, September 23, 2007;
153. Dallas L. Salisbury, "Tough Choices Ahead: Candidates Ignore Pain of Needed Cuts to Health Care," The Commonwealth Fund (January 2008).
154. Richard B. Saltman, "Melting Public-Private Boundaries in European Health Systems," The European Journal of Public Health 13, no. 1 (2003): 24-29.
155. Richard B. Saltman and Josep Figueras, European Health Care Reform: Analysis of Current Strategies (Copenhagen: WHO Regional Publications, 1997): 100.
156. AARP, European Experiences with Health Care Cost Containment: France, The Netherlands, Norway, and The United Kingdom (Washington, D.C.: AARP, 2006), http://assets.aarp.org/www.aarp.org_/cs/gap/ldrstudy_costcontain.pdf.
157. Saltman and Figueras, European Health Care Reform; Richard B. Saltman, Reinhard Busse, and Josep Figueras, Social Insurance Systems in Western Europe (Maidenhead, U.K.: Open University Press, 2004).
158. Corina Sorenson, Michael Drummond, and Panos Kavanos, "Ensuring Value for Money in Health Care: The Role of Health Technology Assessment in the European Union," European Observatory Series, no. 11 (Copenhagen: WHO Regional Office for Europe, 2008).
159. Elias Mossialos, Monique Mrazek, and Tom Walley, ed., Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity, and Quality (Maidenhead, U.K., Open University Press, 2004);
160. Organization for Economic Cooperation and Development, Health at a Glance: OECD Indicators 2003 (Paris: OECD, 2003).
161. Technological Change in Health Care Research Network, "Technological Change Around the World: Evidence from Heart Attack Care," Health Affairs 20, no. 30 (2001): 25-42.
162. Organization for Economic Cooperation and Development, Projecting OECD Health and Long-Term Care Expenditures: What Are the Main Drivers? (Paris: OECD, 2006), http://www.oecd.org/dataoecd/57/7/36085940.pdf/.
163. Gerard F. Anderson et al., "It's the Prices Stupid: Why the United States Is So Different from Other Countries," Health Affairs 22, no. 3 (2003): 101.
164. Robert G. Evans et al., "The 20 Year Experiment: Accounting for, Explaining, and Evaluating Health Care Cost Containment in Canada and the United States," Annual Review of Public Health 12 (1991): 481-518.
165. The National Health Insurance Act, HR 676, 110th Congress.
166. The Physicians Working Group for Single-Payer National Health Insurance, "Proposal of the Physicians' Working Group for Single-Payer National Health Insurance," JAMA 290, no. 6 (2003): 798-805.
167. Robert J. Blendon and Karen Donelan, "The Public and the Emerging Debate over National Health Insurance," New England Journal of Medicine 323, no. 3 (1990).
168. Robert J. Blendon and John M. Benson, "Americans' Views on Health Policy: A Fifty-Year Historical Perspective," Health Affairs 20, no. 2 (2001): 33-46.
169. Robert J. Blendon et al., "The Implications of the 1992 Presidential Election for Health Care Reform," JAMA 268, no. 23 (1993): 3373.
170. Jennifer P. Ruger, "Health, Health Care, and Incompletely Theorized Agreements: A Normative Theory of Health Policy Decision Making," Journal of Health Politics, Policy and Law 32, no. 1 (2007): 74.
171. Jill Quadagno, One Nation Uninsured: Why the U.S. Has No National Health Insurance (New York: Oxford University Press, 2005).
172. David M. Cutler, Your Money or Your Life: Strong Medicine for America's Health Care System (New York: Oxford University Press, 2004): 62.
173. Daniel Callahan, "Using Humans for Research," in What Price Better Health: Hazards of the Research Imperative (Berkeley: University of California Press, 2003).
174. Jack E. Triplett, ed., Measuring the Prices of Medical Treatments (Washington, D.C.: The Brookings Institution Press, 1999);
175. Kevin A. Murphy and Robert H. Topel, Measuring the Gains from Medical Research: An Economic Approach (Chicago: The University of Chicago Press, 2003).
176. Josep Figueras et al., Health Systems, Health, and Wealth: Assessing the Case for Investing in Health (Copenhagen: World Health Organization and the European Observatory, 2008): 65.
177. Stephen Martin, Nigel Rice, and Peter C. Smith, "Does Health Care Spending Improve Health Outcomes? Evidence from English Programme Budgeting Data," Journal of Health Economics 27, no. 4 (2008): 826-42.
178. Gina Kolata, "Co-Payments Go Way Up for Drugs with High Prices," New York Times, April 14, 2008.
179. United Health Foundation, America's Health Rankings 2005 (Washington, D.C.: United Health Foundation, 2005), http://www.unitedhealthfoundation.org/shr2005/ahr05_email.pdf.
180. Alan Garber, Dana P. Goldman, and Anupam B. Jena, "The Promise of Health Care Cost Containment," Health Affairs 26, no. 6 (2007): 1545-47.
181. Henry J. Aaron and William B. Schwartz, Can We Say No? The Challenge of Rationing Health Care (Washington, D.C.: The Brookings Institution Press, 2005): 3.
182. Corina Sorenson, Michael Drummond, and Panos Kavanos, "Ensuring Value for Money in Health Care: The Role of Health Technology Assessment in the European Union," European Observatory Series no. 11 (Copenhagen: WHO Regional Office for Europe, 2008).
183. See also Marcial Velasco Garrido, et al. "Health Technology Assesment and Health Policy-Making in Europe," European Observatory Series No. 14 (Copenhagen: WHO Regional Office for Europe, 2008).
184. David Meltzer, "Can Medical Cost-Effectiveness Analysis Identify the Value of Research?" in Measuring the Gains from Medical Research: An Economic Approach, ed. Kevin A. Murphy and Robert H. Topel (Chicago: The University of Chicago Press): 211.
185. Corina Sorenson et al, "Ensuring Value for Money in Health Care"; see also, Drew Laughland et al., "Exploring the Role of Cost-benefit Analysis in Government Regulations," AARP Public Policy Institute (Washington, D.C.: AARP, 2007).
186. Marthe Gold, "Panel on Cost-Effectiveness in Health and Medicine," Medical Care 34, no. 12 (1996) supplement: DS197-DS199.
187. John Harris, "NICE Is Not Cost Effective," Journal of Medical Ethics 32, no. 7 (2006): 378-380;
188. Karl Claxton and Anthony J. Culyer, "Rights, Responsibilities, and NICE: A Rejoinder to Harris," Journal of Medical Ethics 33, no. 8 (2007): 462-64;
189. Peter H. Schuck and Richard J. Zeckhauser, Targeting in Social Programs (Washington, D.C.: The Brookings Institution Press, 2006).
190. Norman Daniels and James E. Sabin, Setting Limits Fairly: Can We Learn to Share Medical Resources? (New York: Oxford University Press, 2000);
191. Madison Powers and Ruth Faden, "Setting Priorities," in Social Justice: The Moral Foundations of Public Health and Health Policy (New York: Oxford University Press, 2006).
192. Alan Maynard, "Rationing Health Care: An Exploration," Health Policy 49, no. 1-2 (1999): 5-11.
193. Elias Mossialos and Derek King, "Citizens and Rationing: Analysis of a European Survey," Health Policy 49, no. 1-2 (1999): 75-135.
194. Kenneth J. Arrow, "Uncertainty and the Welfare Economics of Medical Care," The American Economics Review 53, no. 5 (1963): 941-973.
195. Burton Weisbrod, "Competition in Health Care: A Cautionary View," in Market Reforms in Health Care: Current Issues, New Directions, ed. Jack Meyers (Washington, D.C.: AEI Press, 1983): 71.
196. James C. Robinson, "The End of Asymmetric Information," Journal of Health Politics, Policy, and Law 26, no. 5 (2001): 1045.
197. Thomas Rice, "Can Markets Give Us the Health System We Want?" Journal of Health Politics, Policy, and Law 22, no. 2 (1997): 384.
198. Thomas Rice, The Economics of Health Reconsidered, 2nd ed. (Chicago: Health Administration Press, 2002): 6.
199. Mark V. Pauly, "Who Was That Straw Man Anyway? A Comment on Evans and Rice," Journal of Health Politics, Policy, and Law 22, no. 2 (1997): 470.
200. Stuart Butler and Edmund Haislmaier, A National Health System for America (Washington, D.C.: The Heritage Foundation Press, 1989).
201. Alain Enthoven, "Introducing Market Forces in Health Care: A Tale of Two Countries" (paper presented at the Fourth European Conference on Health Economics, Paris, France, July 10, 2002).
202. Stephen M. Davidson et al., "Competition and Quality among Managed Care Plans in the U.S.A.," International Journal for Quality in Health Care 10, no. 5 (1998): 411-419.
203. Jonathan Gruber, "The Effect of Competitive Pressure on Charity: Hospital Responses to Price Shopping in California." Journal of Health Economics 13, no. 2 (1994): 183-212.
204. Patrick A. Rivers, Saundra Glover, George Monchus, "Hospital Competition in Major U.S. Metropolitan Areas: Empirical Evidence," Journal of Health and Health Services Administration, Summer 2000: 37-49.
205. Harold Luft et al., "Hospital Competition, Cost and Medical Practice," The Journal of Medical Practice Management 4, no. 1 (1988): 10-15.
206. Glenn A. Melnick and Jack Zwanziger, "Hospital Behavior under Competition and Cost-Containment Policies: The California Experience, 1980 to 1985," JAMA 260, no. 18 (1988): 2669-2675.
207. Thomas L. Gift, Richard Arnould, Larry De Brock, "Healthy Competition Healthy?" Inquiry 39 (2002): 45-55.
208. R. Town and G. Vistnes, "Hospital Competition in HMO Networks." Journal of Health Economics 20 (2001): 733-753.
209. Gautam Gowrisankaranand and Robert J. Town, "Competition, Payers, and Hospital Quality," Health Services Research 38, no. 6 (2003): 1403-1421.
210. P. A. Rivers and M. D. Fottler, "Do HMO Penetration and Hospital Competition Impact Quality of Hospital Care?" Health Services Management Research 17, no. 4 (2004): 237-248.
211. Jeanette Rogowski, Arrind K. Jain, and José J. Escarce, "Hospital Competition, Managed Care, and Mortality after Hospitalization for Medical Conditions in California," Health Services Research 42, no. 2 (2007): 682-705.
212. Anil Bemazai, "Price competition and Hospital Cost Growth in the United States (1989-1994)," Health Economics 8, no. 3 (1999): 233-243.
213. Emmett B. Keeler, Glenn Melnick, and Jack Zwanziger, "The Changing Effects of Competition on Non-Profit and For-Profit Hospital Pricing Behavior," Journal of Health Economics 18, no. 1 (1999): 69-86.
214. Thomas Bodenheimer, "High and Rising Health Care Costs. Part I: Seeking an Explanation," Annals of Internal Medicine 142, no. 10 (2005): 852.
215. James C. Robinson, "Consolidation and the Transformation of Competition in Health Care," Health Affairs 23, no. 6 (2004): 20.
216. Bemazai et al., "Price Competition," 233-243.
217. Gerard Anderson, Robert Heyssel, and Robert Dickler, "Competition vs. Regulation: Its Effect on Hospitals." Health Affairs 12, no. 1 (1993): 70-80.
218. James C. Robinson and Harold Luft, "Competition, Regulation, and Hospital Costs, 1982 to 1986," JAMA 260, no. 18 (1988): 2676-2681.
219. Jack Zwanziger and Glenn A. Melnick, "The Effects of Competition on the Hospital Industry: The Evidence from California," in Competitive Approaches to Health Care Reform, ed. Robert J. Arnould, Robert F. Rich, and William D. White (Washington, D.C.: The Urban Institute Press, 1993): 133.
220. Stephen N. Shortell and Edward F. Hughes, "The Effects of Regulation, Competition, and Ownership on Mortality Rates among Hospital Patients," New England Journal of Medicine 318, no. 17 (1988): 1100-1107.
221. Rogowski et al., "Hospital Competition," 682-705.
222. Kevin G. Volpe and Edward Buckley, "The Effect of Increases in HMO Penetration and Changes in Payer Mix on In-Hospital Mortality and treatment Patterns for Acute Myocardial Infarction," The American Journal of Managed Care 10, no. 7 (2004): 505-512.
223. Douglas A. Wholey, Roger Feldman, and Jon B. Christianson, "The Effect of Market Structure on HMO Premiums," Journal of Health Economics 14, no. 1 (1995): 81-105.
224. Barbara A. Mark, David W. Harless, and Michael McCue, "The Impact of HMO Penetration on the Relationship between Nurse Staffing and Quality," Health Economics 14, no. 7 (2005): 737-753.
225. Dennis P. Scanlon et al., "Competition and Health Plan Performance: Evidence from Health Maintenance Organization Insurance Markets," Medical Care 43, no. 4 (2005): 338-346.
226. Farasat Bokhari, "Managed Care Competition and the Adoption of Hospital Technology: The Case of Cardiac Catheterization," http://129.3.20.41/eps/hew/papers/0110/0110001.pdf.
227. Patrick A. Rivers and Myron D. Fottler, "Do HMO Penetration and Hospital Competition Impact Quality of Hospital Care?" Health Services Management Research 17, no. 4 (2004): 237-248.
228. Walton Francis, Using the Federal Employees' Model: Nine Tests for Rational Medicare Reform: Heritage Foundation Backgrounder #1675 (Washington, D.C.: The Heritage Foundation, 2003);
229. David Gratzer, The Cure: How Capitalism Can Save American Health Care (New York: Encounter Books, 2006).
230. American Federation of Government Employees, 2007 Issue Paper Federal Employees Health Benefits Program (Washington, D.C.: AFGE, 2007), http://www.afge.org/index.cfm?page=ContentTest&Fuse=Content&ContentID=996.
231. U.S. Office of Personnel Management, "Federal Employees Health Benefits Program," http://www.opm.gov/insure/health/.
232. John E. Dicken, Director of Health Care, Government Accountability Office, testimony before the Subcommittee on Oversight of Government Management, Friday, May 18, 2007.
233. John K. Iglehart, "The Emergence of Physician-Owned Specialty Hospitals," New England Journal of Medicine 352, no. 1 (2005): 78-84.
234. Medicare Payment Advisory Commission (MEDPAC), Report to the Congress: Physician-Owned Specialty Hospitals Revisited (Washington, D.C.: Medicare Payment Advisory Commission, 2006).
235. Robert L. Ohsfeldt and John E. Schneider, The Business of Health: The Role of Competition, Markets, and Regulation (Washington, D.C.: AEI Press, 2006).
236. Gratzer, The Cure.
237. Frederick T. Schut and Wynand Van de Ven, "Rationing and Competition in the Dutch Health Care System," Health Economics 14, supplement 1 (2005): S59.
238. Timothy Stoltzfus Jost, Diane Dawson, Andre de Exter, "The Role of Competition in Health Care: A Western European Perspective," Journal of Health Politics, Policy and Law 31, no. 3 (2006): 688-703;
239. Richard Freeman, "Competition in Context: The Politics of Heath Care Reform in Europe," International Journal for Quality in Health Care 10, no. 5 (1998): 395-401.
240. Thomas Schlesinger, ed., "Federal Trade Commission Report on Health Care and Competition," special issue, Journal of Health Politics, Policy, and Law 31, no. 3 (2006).
241. Alain Enthoven, "A Living Model of Managed Competition: A Conversation with Dutch Health Minister Ab Klink," Health Affairs, Web Exclusive (2008): W196-203.
242. Hans Maarse, personal communication, 2007.
243. Paul Vaillancourt Rosenau and Christiaan Lako, "An Experiment with Regulated Competition and Individual Mandates for Universal Health Care: The New Dutch Health Insurance System," Journal of Health Politics, Policy and Law 33, no. 6 (2008): 1031.
244. Hans Maarse and Rud Ter Meulen, "Consumer Choice in Dutch Health Insurance after Reform," Health Care Analysis 14, no. 1 (2006): 37-49.
245. Timothy S. Jost, "The Future of Medicare, Post Great Society and Post Plus-Choice: Legal and Policy Issues,"Washington and Lee Law Review 60, no. 4 (2003): 1087-1094.
246. Joseph White, "Markets and Medical Care: The United States, 1993-2005," The Milbank Quarterly 85, no. 3 (2007): 432.
247. Michael E. Porter and Elizabeth O. Teisberg, Redefining Health Care: Creating Value-Based Competition on Results (Boston: Harvard Business School Press, 2006);
248. Gratzer, The Cure; John F. Cogan, R. Glenn Hubbard, Daniel P. Kessler, Healthy, Wealthy, and Wise: Five Steps to a Better Health Care System (Washington, D.C.: AEI Press, 2005);
249. Robert L. Ohsfeldt and John E. Schneider, The Business of Health: The Role of Competition, Markets, and Regulation (Washington, D.C.: The AEI Press, 2006).
250. Ohsfeldt and Schneider, The Business of Health.
251. Michael F. Cannon and Michael D. Tanner, Healthy Competition: What's Holding Back Health Care and How to Free It (Washington, D.C.: The Cato Institute, 2005): 5.
252. John F. Coogan, R. Glen Hubbard, and Daniel P. Kessler, Healthy,Wealthy, & Wise (Washington, D.C.: The AEI Press, 2005).
253. Porter and Teisberg, Redefining Health Care.
254. Hans Maarse, personal communication, 2007.
255. Daniel Callahan and Angela Wassuna, "The Value of the Market: What Does the Evidence Show?" in Medicine and the Market: Equity v. Choice (Baltimore: Johns Hopkins University Press, 2006).
256. Jacob S. Hacker, "The Case for Public Health Choice in National Health Reform: Key to Cost Control and Quality Coverage" (Berkeley: Center on Health, Economic & Family Security, University of California, Berkeley, School of Law, December 2008).
257. Seymour Perry, "The Brief Life of The National Center for Health Care Technology," New England Journal of Medicine 307, no. 17 (1982): 1096.
258. Shannon Brownlee, Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer (New York: Bloomsbury, 2007): 293.
259. Susan B. Foote, Managing the Medicare Arms Race: Public Policy and Medical Device Innovation (Berkeley: University of California Press, 1992);
260. Marcia Angell, The Truth about Drug Companies: How They Deceive Us and What to Do about It (New York: Random House, 2004);
261. Jerry Avorn, "Rethinking Research Funding," Boston Globe, May 7, 2007;
262. Donald L. Bartlett and James B. Steele, Critical Condition: How Health Care in America Became Big Business-and Bad Medicine (New York: Doubleday Press, 2004).
263. Anupam B. Jena and Tomas Phillipson, "Cost-Effectiveness as a Price Control," Health Affairs 26, no. 3 (2007): 696-703.
264. Richard A. Deyo and Donald L. Patrick, "Hope or Hype: The Obsession with Medical Advances and the High Cost of False Promises," (New York: American Management Association, 2004): 79.
265. Angell, The Truth About Drug Companies; Deyo and Patrick, "Hope or Hype"; Avorn, "Rethinking Research Funding"; Bartlett and Steele, Critical Condition; Daniel Callahan and Angela Wasunna, Medicine and the Market: Equity v. Choice (Baltimore: Johns Hopkins University Press, 2006).
266. Bartlett and Steele, Critical Condition 120.
267. Peter Conrad, The Medicalization of Society (Baltimore: Johns Hopkins University Press, 2007): 4.
268. Leonard M. Fleck, "The Costs of Caring: Who Pays? Who Profits? Who Panders?" Hastings Center Report 36, no. 3 (2006): 13-17.
269. Avorn, "Rethinking Research Funding."
270. Stephen Heuser, "Tough Criticisms Rise as Biotech Matures," Boston Globe, May 8, 2007.
271. Joseph P. Newhouse, "How Much Should Medicare Pay for Drugs?" Health Affairs 23, no. 1 (2004): 89-102.
272. Arnold S. Relman, A Second Opinion: Rescuing America's Health Care (New York: Public Affairs, 2007): 5.
273. Rosemary A. Stevens, "History and Health Policy in the United States: The Making of a Health Care Industry, 1948-2008" Social History of Medicine 21, no. 3: 483.
274. John K. Iglehart, "The Emergence of Physician-Owned Specialty Hospitals," New England Journal of Medicine 352, no. 1 (2005): 78-84.
275. Robert A. Berenson, Paul B. Ginsburg, and Jessica H. May, "Hospital-Physician Relations: Cooperation, Competition, or Separation?" Health Affairs (Web Exclusive, 2006): W34.
276. Jeff Goldsmith, "Hospitals and Physicians: Not a Pretty Picture," Health Affairs (Web Exclusive, 2006): W73.
277. Jean M. Mitchell, "The Prevalence of Physician Self-Referral Arrangements after Stark II: Evidence from Advanced Diagnostic Imaging," Health Affairs (Web Exclusive 2007): W415-W435.
278. Stephanie Maxwell, Stephen Zuckerman, and Robert A. Berenson, "Use of Physicians' Services under Medicare's Resource-Based Payment," New England Journal of Medicine 356, no. 18 (2007): 1853-1861.
279. Newhouse, "How Much Should Medicare Pay for Drugs?"
280. Dana Gelb Safran, "Defining the Future of Primary Care: What Can We Learn from Patients," Annals of Internal Medicine 130, no. 3 (2003): 248.
281. Thomas Bodenheimer, Robert A. Berenson, and Paul Rudolph, "The Primary Care-Specialty Income Gap-Why It Matters," Annals of Internal Medicine 146, no. 4 (2007): 301-306.
282. Thomas Bodenheimer, "Primary Care-Will It Survive?" New England Journal of Medicine 355, no. 9 (2006): 862.
283. Beverly Woo, "Primary Care: The Best Job in Medicine," New England Journal of Medicine 355, no. 9 (2006): 866.
284. Mark A. Rodwin, Hak J. Chang, and Jeffrey Clausen, "Malpractice Premiums and Physicians' Income: Perceptions of a Crisis Conflict with Empirical Evidence," Health Affairs 25, no. 1 (2006): 750-758.
285. Jack M. Colwill, James M. Cultice, and Robin L. Kruse, "Will Generalist Physician Supply Meet Demands of an Increasing and Aging Society?" Health Affairs, Web Exclusive (April 2008): 232-241.
286. Relman, A Second Opinion, 166.
287. Daniel Callahan, False Hopes: Overcoming the Obstacles to a Sustainable, Affordable Medicine (New York: Simon & Schuster, 1998).
288. John A. Vincent, "Science and Imagery in the 'War on Old Age,' " Aging and Society 29 (2007): 941-961.
289. René Dubos, The Mirage of Health: Utopias, Progress, and Biological Change (New York: Harper Colophon, 1979): 2.
290. Michael Walzer, Spheres of Justice: A Defense of Pluralism and Equality (New York: Basic Books, 1983): 88.
291. Daniel Callahan, Living with Mortality: In Search of a Peaceful Death (New York: Simon and Schuster, 1993).
292. Daniel Callahan,What Price Better Health: Hazards of the Research Imperative (Berkeley: University of California Press, 2003).
293. Jessica H. Miller and Barbara Koenig, "On the Boundary of Life and Death," in Biomedicine Examined, ed. Margaret Lock and Deborah Gordon (Dordrecht: Kluwer Academic Publishers, 1988): 369.
294. Christine Overall, Aging, Death and Human Longevity (Berkeley: University of California Press, 2003).
295. William Haseltine, quoted in Lawrence M. Fisher, "The Race to Cash in on the Genetic Code," New York Times, August 29, 1999.
296. Nicholas Agar, "Whereto Transhumanism?" Hastings Center Report 37, no. 3 (2007): 12-17.
297. Geoffrey Scarre, Death (Montreal: McGill-Queen's University Press, 2007).
298. Vincent, "Science and Imagery," 941.
299. Seneca, quoted in Scarre, Death, 35.
300. Judith Feder and Donald W. Moran, "Cost Containment and the Politics of Health Care Reform," in Restoring Fiscal Sanity 2007: The Health Spending Challenge, ed. Alice M. Rivlin and Joseph R. Antos (Washington, D.C.: The Brookings Institution, 2007): 186.
301. Joanne Lynn, Sick to Death: And Not Going to Take It Anymore (Berkeley: University of California Press, 2004).
302. Cited in Jacqueline Fox, "Medicare Should, but Cannot, Consider Costs: Legal Impediments to a Sound Policy," Buffalo Law Review 53, no. 2 (2005): 590-591.
303. Mark A. Hall, "State Regulation of Medical Necessity: The Case of Weight-Reduction Surgery," Duke Law Journal 53 (2003): 671.
304. David M. Eddy, "Evidence-Based Medicine: A Unified Approach," Health Affairs 24, no. 1 (2005): 9-17.
305. James C. Robinson, "The End of Managed Care," JAMA 285, no. 20 (2000): 2622.
306. Jean R. Tunis, "Why Medicine Has Not Established Criteria for Coverage Decisions," New England Journal of Medicine 350, no. 21 (2004): 2197.
307. Peter J. Neumann, Allison B. Rosen, and Milton C. Weinstein, "Medicare and Cost Effectiveness Analysis," New England Journal of Medicine 353, no. 14 (2005): 1519.
308. Jacqueline Fox, "Medicare Should, but Cannot, Consider Cost: Legal Impediments to a Sound Policy," Buffalo Law Review 53, no. 2 (2005): 632.
309. Muriel G. Gillick, "Medicare Coverage for Technological Innovations: Time for New Criteria?" New England Journal of Medicine 350 (2004): 2199-2203.
310. Peter S. Neumann, Maki S. Kamae, Jennifer A. Palmer, "Medicare's National Coverage Decisions for Technologies, 1999-2007," Health Affairs 24, no. 1 (2008): 1620.
311. Tunis, "Why Medicare Has Not Established Criteria," 2197.
312. Fox, "Medicare Should, but Cannot, Consider Cost," 611.
313. David Eddy, quoted in Peter A. Glassman et al., "The Role of Medical Necessity and Cost-Effectiveness in Making Medical Decisions," Annals of Internal Medicine 126, no. 2 (1997): 152.
314. Gillick, "Medicare Coverage for Technological Innovations," 2201.
315. Fox, "Medicare Should, but Cannot, Consider Cost."
316. Neumann, Rosen, and Milton, "Medicare and Cost Effectiveness Analysis," 1518.
317. Thomas E. Getzen, "Health Care Is an Individual Necessity and a National Luxury: Applying Multilevel Decision Models to the Analysis of Health Care Expenditures," Journal of Health Economics 19 (2000): 268.
318. Guillem Lopez, personal communication, October 30, 2007.
319. Daniel Callahan, Setting Limits: Medical Goods in an Aging Society (New York: Simon & Schuster: 1987).
320. Alexander M. Capron, "Ethical Aspects of Major Increases in Life Span and Life Expectancy," in Coping with Methuselah: The Impact of Molecular Biology and Society, ed. Henry J. Aaron and William B. Schwartz (Washington, D.C.: Brookings Institution Press, 2004).
321. Christine Overall, Aging, Death and Human Longevity (Berkeley: University of California Press, 2003).
322. John A. Vincent, "Science and Imagery in the 'War on Old Age,'" Ageing and Society 27 (2007): 941.
323. Joel Mokyr, The Lever of Riches: Technological Creativity and Economic Progress (New York: Oxford University Press, 1990): 210.
324. Barnaby J. Feder, "A Lifesaver, but the Risks Give Pause," New York Times, September 13, 2008.
325. Gerald F. Ailey, "Long-Term Trends in the Concentration of Medicare Spending," Health Affairs 26, no. 3 (2007): 808-819.
326. Dana P. Goldman et al., "Consequences of Health Trends and Medical Innovation for the Future Elderly," Health Affairs 24, suppl. 2 (2005): R5-17.
327. Donald R. Hoover et al., "Medical Expenditures during the Last Year of Life: Findings from the 1992-1996 Medicare Current Beneficiary Survey," HSR: Health Services Research 37, no. 6 (2002): 1625-1642;
328. Michael Raitano, "The Impact of Death-Related Costs on Healthcare Expenditure: A Survey," ENEPRI Report no. 17 (2006).
329. Hoover et al., "Medical Expenditures"; James Lubitz, "Health, Technology, and Medical Care Spending," Health Affairs 24 (web exclusive, 2005): W81-W85.
330. Meena Seshamahi and Alastair M. Gray, "A Longitudinal Study of the Effects of Age and Time to Death on Hospital Costs," Journal of Health Economics 23 (2004): 222-223.
331. Christopher Hogan et al., "Medicare Beneficiaries' Cost of Care in the Last Year of Life," Health Affairs 20, no. 4 (2001): 192.
332. Marc L. Berk and Alan C. Monheit, "The Concentration of Health Care Expenditures, Revisited," Health Affairs 20, no. 2 (2001): 9-18;
333. Gerald F. Riley, "Long-Term Trends in the Concentration of Medicare Spending," Health Affairs 26, no. 3 (2007): 808-819.
334. Berk and Monheit, "The Concentration of Health Care Expenditures, Revisited," 110, 112.
335. James Lubitz et al., "Health, Life Expectancy, and Health Care Spending among the Elderly," New England Journal of Medicine 249, no. 11 (2003): 1048;
336. Hoover et al., "Medical Expenditures," 1639.
337. Dartmouth Atlas Project, "The Care of Patients with Severe Chronic Illness: A Report on the Medicare Program by the Dartmouth Atlas Project," http://www.dartmouthatlas.org/atlases/2006_Atlas_Exec_Summary.pdf.
338. Elliott S. Fisher et al., "The Implications of Regional Variations in Medicare Spending, Part 2: Health Outcomes and Satisfaction with Care," Annals of Internal Medicine 138, no. 4 (2003): 288-298.
339. Dartmouth Atlas Project, "The Care of Patients," 2.
340. Daniel Callahan and Angela A. Wasunna, Medicine and the Market: Equity v. Choice (Baltimore: Johns Hopkins University Press, 2006).
341. Christopher J. L. Murray et al., "Eight Americas: Investigating Mortality Disparities across Races, Counties, and Race-Counties in the United States," PLoS Medicine 3, no. 9 (2006): 1513-1524;
342. David Mechanic, "Population Health: Challenges for Science and Society," The Milbank Quarterly 85, no. 3 (2007): 533-559.
343. David A. Kindig takes a somewhat different route to a public health model in "A Pay-for-Population Health Performance," JAMA 296, no. 21 (2006).
344. Daniel Callahan, What Kind of Life: The Limits of Medical Progress (New York: Simon & Schuster, 1990): 176-177.
345. Michael D. Rawlins and Anthony J. Culyer, "National Institute for Clinical Excellence and Its Value Judgments" British Medical Journal 329, no. 7459 (2004): 224.
346. Thomas R. Frieden and Farzad Mostashari, "Health Care as if Health Mattered," JAMA 299, no. 8 (2008): 950.
347. Shannon Brownlee, Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer (New York: Bloomsbury, 2007).
348. Robin Hanson, "Cut Medicine in Half," Cato Unbound Blog, the Cato Institute, September 10, 2007. http://www.cato-unbound.org/2007/09/10/robin-hanson/cut-medicine-in-half/
349. Ellen Nolte and C. Martin McKee, "Measuring the Health of Nations: Updating an Earlier Analysis," Health Affairs (January/February 2008): 98.
350. Karen Schoen et al., "Bending the Curve: Options for Achieving Savings and Improved Value in U.S. Health Spending," The Commonwealth Fund 80 (November 18, 2007), http://www.Commonwealthfund.org/publications/publications_show.htm?doc_id==620087.
351. Gregg Easterbrook, The Progress Paradox: How Life Gets Better while People Feel Worse (New York: Random House, 2003).
352. Arthur J. Barsky, Worried Sick: Our Troubled Quest for Wellness (Boston: Little Brown, 1988).
353. Jonathan Cohn, "Creative Destruction: The Best Case against Universal Health Care, The New Republic (November 19, 2007), 28.
354. Daniel Callahan, "Advocacy and Priorities for Research," in What Price Better Health: Hazards of the Research Imperative (Berkeley: University of California Press, 2006), Chapter 6.
355. Steven H. Woolf, "Potential Health and Economic Consequences of Misplaced Priorities," JAMA 29, no. 5 (2007): 523.
356. Richard Dolinar, "Evidence-Based Medicine vs. Patients," TCS Daily (December 17, 2007).
357. Samuel H. Preston, "Children and the Elderly: Divergent Paths for America's Dependents," Demography 21 (1984): 491.
358. Daniel Callahan, Setting Limits: Medical Goals in an Aging Society (New York: Simon & Schuster, 1987).
359. Gardiner Harris, "British Balance Benefit vs. Cost of Latest Drugs," The New York Times, December 3, 2008: A1.
360. K. Robin Yabroff, et al., "Projections of Costs Associated with Colorectal Cancer Care in the United States," Health Economics 17 (2008): 955.
361. K. Robin Yaroff, et al. "Cost of Care for Elderly Cancer Patients in the United States, Journal of the National Cancer Institute 100, no. 9 (2008): 640.